Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Union Minister of State (Independent Charge) for Science & Technology, Earth Sciences; MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today inaugurated the ...

Portfolio of CTGrade cytokines and growth factors contain no animal- or human-derived materials Expansion of CTGrade portfolio resulting from the acquisition by FUJIFILM Irvine Scientific earlier this ...

Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ...

Union Minister Jitendra Singh inaugurated a new biotechnology facility and dedicated a national facility for recombinant cells and sensors at the Rajiv Gandhi Centre for Biotechnology in ...

Minister for Science and Technology Jitendra Singh on Sunday inaugurated a new biotechnology research facility at the Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram aimed at ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...

Twenty-seven entreaties drafted and endorsed following discussions at the 50-year anniversary summit of the 1975 Asilomar Conference on Recombinant DNA have been published and archived at Rice ...

THE STRUCTURE AND FUNCTION OF RECOMBINANT HUMANIZED TYPE III COLLAGEN AS WELL AS ITS RELATED PRODUCT approved by CHINA NMPa for COSMETICS USE (ADAPTED FROM THE AUTHORS’ PUBLICATION IN Biochemical and ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...